Common ground for the control of multidrug-resistant Salmonella in ground beef

Clinical Infectious Diseases

Volumn 42, Issue 10, 2006, Pages 1455-1462

  Talbot, Elizabeth A ^a,b,c   Gagnon, Elizabeth R ^a   Greenblatt, Jesse ^a  

^a NEW HAMPSHIRE DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^b DARTMOUTH COLLEGE   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFALOTIN; CEFOXITIN; CEFTIOFUR; CEFTRIAXONE; CHLORAMPHENICOL; KANAMYCIN; STREPTOMYCIN; SULFAMETHOXAZOLE; TETRACYCLINE;

ANIMAL DISEASE; ANTIMICROBIAL ACTIVITY; CONSUMER; EPIDEMIC; FOOD CONTROL; FOOD SAFETY; GROUND BEEF; HUMAN; INFECTION CONTROL; MEAT; MEAT INDUSTRY; MULTIDRUG RESISTANCE; NONHUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; REVIEW; SALMONELLA; SALMONELLA ENTERICA; SALMONELLA ENTERICA TYPHIMURIUM DT 104; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SEROTYPE;

ANIMALS; CATTLE; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE; HUMANS; MEAT; SALMONELLA; SALMONELLA INFECTIONS; UNITED STATES;

EID: 33646442171     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/503572     Document Type: Review

References (51)

1. Thuluvath PJ, McKendrick MW. Salmonella and complications related to age-Sheffield experience. Q J Med 1988; 67:497-503.
2. Angulo FJ, Swerdlow DL. Bacterial enteric infections in persons infected with human immunodeficiency virus. Clin Infect Dis 1995; 21(Suppl 1):S84-93.
3. Varma JK, Molbak K, Barett TJ, et al. Antimicrobial-resistant nontyphoidal Salmonella is associated with excess bloodstream infections and hospitalizations. J Infect Dis 2005; 191:554-61.
4. Martin LJ, Fyfe M, Doré K, et al. Increased burden of illness associated with antimicrobial-resistant Salmonella enterica serotype Typhimurium infections. J Infect Dis 2004; 189:377-84.
5. Helms M, Vastrup P, Gerner-Smidt P, Molbak K. Excess mortality-associated with antimicrobial drug-resistant Salmonella Typhimurium. Emerg Infect Dis 2002; 8:490-5.
6. Molbak K. Human health consequences of antimicrobial drug-resistant Salmonella and other foodborne pathogens. Clin Infect Dis 2005;41:1613-20.
7. Varma JK, Greene KD, Ovitt I, Medalla F, Angulo F. Hospitalization and antimicrobial resistance in Salmonella outbreaks, 1984-2002. Emerg Infect Dis 2005; 11:943-6.
8. Voetsch AC, Van Gilder TJ, Angulo FJ, et al. FoodNet estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States. Emerging Infections Program FoodNet Working Group. Clin Infect Dis 2004;38(Suppl 3):S127-34.
9. Centers for Disease Control and Prevention. Outbreak of multidrug-resistant Salmonella Newport-United States, January-April 2002. MMWR Morb Mortal Wkly Rep 2002; 51:545-8.
10. Dechet AM, Scallan E, Gensheimer K, et al. Outbreak of multidrug resistant Salmonella Typhimurium DT104 infections linked to commercial ground beef-Northeastern United States, 2003-2004. Clin Infect Dis 2006; 42:747-52.
11. Gupta A, Fontana J, Crowe C, et al. Emergence of multidrug-resistant Salmonella enterica serotype Newport infections resistant to explanded-spectrum cephalosporins in the United States. J Infect Dis 2003; 188:1707-16.
12. Spika JS, Waterman SH, Soo Hoo GW, et al. Chloramphenicol-resistant Salmonella Newport traced through hamburger to dairy farms: a major persisting source of human salmonellosis in California. N Engl J Med 1987; 316:565-70.
13. Glynn MK, Reddy V, Hutwagner L, et al. Prior antimicrobial agent use increases the risk of sporadic infections with multidrug-resistant Salmonella enterica serotype Typhimurium: a FoodNet case-control study, 1996-1997. Clin Infect Dis 2004; 38(Suppl 3):S227-36.
14. Villar RG, Macek MD, Simons S, et al. Investigation of multidrug-resistant Salmonella serotype Typhimurium DT104 infections linked to raw-milk cheese in Washington State. JAMA 1999; 281:1811-6.
15. MacDonald KL, Cohen ML, Hargett-Bean NT, et al. Changes in antimicrobial resistance of Salmonella isolated from humans in the United States. JAMA 1987; 258:1496-9.
16. Centers for Disease Control and Prevention. National antimicrobial resistance monitoring system for enteric bacteria (NARMS): 2002 Human isolates final report. 2004. Available at: http://www.cdc.gov/narms/. Accessed 17 October 2005.
17. Glynn MK, Bopp C, Dewitt W, Dabney P, Mokhtar M, Angulo FJ. Emergence of multidrug-resistant Salmonella enterica serotype DT104 infections in the United States. N Engl J Med 1998;338:1333-8.
18. United States Department of Agriculture, Animal Plant Health Inspection Service, Centers for Epidemiology and Animal Health. Prevalence and antimicrobial susceptibility patterns of Salmonella from beef cows. 2001. Available at: http://www.aphis.usda.gov/vs/ceah/ncahs/nahms/beefcowcalf/. Accessed 17 October 2005.
19. Dargatz DA, Fedorka-Cray PJ, Ladely SR, Kopral CA, Ferris KE, Headrick ML. Prevalence and antimicrobial susceptibility of Salmonella spp. isolates from U.S. cattle in feedlots in 1999 and 2000. J Appl Microbiol 2003; 95:753-61.
20. Tankson JD, Cray PJ, Headrick, M. 2000 NARMS report of Salmonella Newport slaughter and on-farm isolates [session 91, C2-865]. In: Program and abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago). 2003:126.
21. United States Department of Agriculture, Antimicrobial Resistance Research Unit. National antimicrobial resistance monitoring system for enteric bacteria (NARMS): NARMS animal annual report, 2003. Available at: http://ars.usda.gov/Business/docs.htm?docid = 6764. Accessed 17 October 2005.
22. White DG, Zhao S, Sudler R, et al. The isolation of antibiotic-resistant Salmonella from retail ground meats. N Engl J Med 2001; 345:1147-54.
23. United States Food and Drug Administration, Center for Veterinary Medicine. National antimicrobial resistance monitoring system for enteric bacteria (NARMS): NARMS retail meat annual report, 2003. Available at: http://www.fda.gov/cvm/coversheet2003.htm. Accessed 17 October 2005.
24. Knobler SL, Lemon SM, Najafi M, Burroughs T, eds. The resistance phenomenon in microbes and infectious disease vectors: implications for human health and strategies for containment-workshop summary. Washington, DC: National Academies Press, 2003.
25. Cohen ML, Tauxe RV. Drug-resistant Salmonella in the United States: an epidemiological perspective. Science 1986; 234:964-9.
26. Levy SB. Antibiotic resistance: an ecological imbalance. In: Levy SB, Goode J, Cahdwidck DJ, eds. Antibiotic resistance: origins, evolution, selection, and spread. New York: John Wiley & Sons, 1997:1-9.
27. van den Bogaard AE, Stobberingh EE. Antibiotic usage in animals: impact on bacterial resistance and public health. Drugs 1999; 58:589-607.
28. World Health Organization (WHO). WHO global principles for the containment of antimicrobial resistance in animals intended for food. 2000. Available at: http://www.who.int/foodborne_disease/resistance/en. Accessed 28 November 2005.
29. World Health Organization (WHO). Critically important antibacterial agents for human medicine for risk management strategies of non-human use: Report of a WHO working group consultation, Canberra, Australia, 15-18 February 2005. 2005. Available at: http://www.who.int/foodborne_disease/resistance/en. Accessed 23 November 2005.
30. Wegener HC, Aarestrup FM, Jensen LB, Hammerum AM, Eager F. Use of antimicrobial growth promoters in food animals and Enterococcus faedum resistance to therapeutic antimicrobial drugs in Europe. Emerg Infect Dis 1999; 5:329-35.
31. Aarestrup FM, Seyfarth AM, Emborg H-D, Pedersen K, Henderiksen RS, Bager F. Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark. Antimicrob Agents Chemother 2001; 45:2054-9.
32. United States Food and Drug Administration. Guidance for industry 152: evaluating the safety of antimicrobial new animal drugs with regard to their microbiological effects on bacteria of human health concern. 2003. Available at: http://www.fda.gov/cvm/. Accessed on 17 October 2005.
33. United States Food and Drug Administration. Proposal to withdraw approval of the new animal drug application for enrofloxacin for poultry (2000N-1571). 2004. Available at: http://www.fda.gov/ohrms/dock ets/dailys/04/mar04/031604/ 031604.htm. Accessed 17 October 2005.
34. Nou X, Rivera-Betancourt M, Bosilevac JM, et al. Effect of chemical dehairing on the prevalence of Escherichia coli O157:H7 and the levels of aerobic bacteria and enterobacteriaceae on carcasses in a commercial beef processing plant. J Food Prot 2003; 66:2005-9.
35. Castillo A, Dickson JS, Clayton RP, Lucia LM, Acuff GR. Chemical dehairing of bovine skin to reduce pathogenic bacteria and bacteria of fecal origin. J Food Prot 1998; 61:623-5.
36. Bosilevac IM, Nou X, Osborn MS, Allen DM, Koohmaraie M. Development and evaluation of an on-line hide decontamination procedure for use in a commercial beef processing plant. J Food Prot 2005;68:265-72.
37. Castillo A, Lucia LM, Goodson KJ, Savell JW, Acuff GR. Decontamination of beef carcass surface tissue by steam vacuuming alone and combined with hot water and lactic acid sprays. J Food Prot 1999; 62:146-51.
38. Centers for Disease Control and Prevention. Preliminary FoodNet data on the incidence of infection with pathogens transmitted commonly through food-10 Sites, United States, 2004. MMWR Morb Mortal Wkly Rep 2005; 54:352-6.
39. Naugle AL, Holt KG, Levine P, Eckel R. Food safety and inspection service regulatory testing program for Escherichia coli O157:H7 in raw ground beef. J Food Prot 2005; 68:462-8.
40. Osterholm MT, Norgan AP. The role of irradiation in food safety. N Engl J Med 2004;350:1898-1901.
41. Tauxe RV. Food safety and irradiation: protecting the public from foodborne infections. Emerg Infect Dis 2001;7(Suppl):516-21.
42. Centers for Disease Control and Prevention. Foodborne diseases active surveillance network population survey atlas of exposures, 2002-2004. Available at: http://www.cdc.gov/foodnet/studies-pages/pop.htm. Accessed 17 October 2005.
43. Altekruse SF, Street DA, Fein SB, Levy AS. Consumer knowledge of foodborne microbial hazards and food-handling practices. J Food Prot 1996;59:287-94.
44. Interagency task force on antimicrobial resistance: a public health action plan to combat antimicrobial resistance. 2001. Available at: http: //www.cdc.gov/drugresistance/actionplan/. Accessed 17 October 2005.
45. Council of State and Territorial Epidemiologists. 2004 National assessment of epidemiologic capacity: findings and recommendations. 2004. Available at: http://www.cste.org/Assessment/ECA/pdffiles/ECA final05.pdf. Accessed 17 October 2005.
46. Matyas B. "National Guidelines for Foodborne Enteric Disease Surveillance and Response." CSTE Position Statement 05-ID-02. 2005. Available at: http://www.cste.org/. Accessed 17 October 2005.
47. Vugia, D. Disclosing food distribution information to protect the public health: CSTE position statement 04-ID-02. 2004. Available at: http://www.cste.org/ps/. Accessed 17 October 2005.
48. Greenblatt J. Improved inter-agency coordination for multi-state outbreaks associated with Salmonella species: CSTE position statement 04-ID-06. 2004. Available at: http://www.cste.org/ps/. Accessed 17 October 2005.
49. Gibson J. CSTE support for the guidelines for coordination of multistate food borne outbreak investigations of the national food safety system outbreak coordination work group: CSTE Position Statement 2000 ID-08. 2000. Available at: http://www.cste.org/ps/2000/2000-id-08.htm. Accessed 17 October 2005.
50. National Food Safety System Project Outbreak Coordination and Investigation Workgroup. Multistate foodborne outbreak investigations: guidelines for improving coordination and communication. 2000. Available at: http.//www.fda.gov/ora/fed_state/NFSS/. Accessed 17 October 2005.
51. Guerrant RL, Van Gilder T, Steiner TS, et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 2001; 32:331-51.